SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 2 filers reported holding SESEN BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 1,000 | -77.3% | 0.00% | – |
| Q3 2022 | $1,000 | – | 4,412 | +130.8% | 0.00% | – |
| Q2 2022 | $0 | – | 1,912 | -45.4% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 3,500 | -96.4% | 0.00% | -100.0% |
| Q4 2021 | $45,000 | -60.2% | 95,913 | -54.8% | 0.00% | -60.0% |
| Q3 2021 | $113,000 | -64.8% | 211,988 | +29.4% | 0.01% | -66.7% |
| Q2 2021 | $321,000 | +241.5% | 163,828 | +172.3% | 0.02% | +275.0% |
| Q1 2021 | $94,000 | +487.5% | 60,158 | +379.3% | 0.00% | +300.0% |
| Q4 2020 | $16,000 | +45.5% | 12,550 | -37.2% | 0.00% | 0.0% |
| Q3 2020 | $11,000 | +1000.0% | 20,000 | +1718.2% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -88.9% | 1,100 | -70.0% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | +50.0% | 3,661 | +120.4% | 0.00% | – |
| Q3 2018 | $6,000 | +20.0% | 1,661 | -35.1% | 0.00% | – |
| Q2 2018 | $5,000 | – | 2,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 4,091,591 | $18,903,000 | 100.00% |
| Schonfeld Strategic Advisors LLC | 3,828,200 | $17,687,000 | 0.19% |
| Virtus ETF Advisers LLC | 52,632 | $243,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 711,500 | $3,287,000 | 0.06% |
| WealthTrust Axiom LLC | 39,750 | $183,000 | 0.06% |
| CAXTON ASSOCIATES LP | 84,801 | $392,000 | 0.04% |
| Stratos Wealth Partners, LTD. | 352,500 | $1,629,000 | 0.04% |
| ClariVest Asset Management LLC | 260,500 | $1,203,000 | 0.04% |
| TWO SIGMA ADVISERS, LP | 2,766,318 | $12,780,000 | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 3,150,574 | $14,556,000 | 0.03% |